Frequencies of chromosomal abnormalities at amniocentesis: Over 20 years of cytogenetic analyses in one laboratory

American Journal of Medical Genetics

Volumn 82, Issue 2, 1999, Pages 149-154

  Caron, Lorraine ^a   Tihy, Frédérique ^b   Dallaire, Louis ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Advanced maternal age; Aneuploidy; Prenatal diagnosis; Recurrence risk

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECURRENCE RISK; TRISOMY 21;

AMNIOCENTESIS; CANADA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRENATAL DIAGNOSIS;

EID: 0033555450     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990115)82:2<149::AID-AJMG10>3.0.CO;2-L     Document Type: Article

References (23)

1. Blennow E, Bui TH, Kristoffersson U, Vujie M, Annerén G, Holmberg E, Nordenskjold M. 1994. Swedish survey on extra structurally abnormal chromosomes in 39,105 consecutive prenatal diagnoses: Prevalence and characterization by fluorescence in situ hybridization. Prenat Diagn 14:1019-1024.
2. Buckton KE, Spowart G, Newton MS, Evans HJ. 1985. Forty four probands with an additional "marker" chromosome. Hum Genet 69:353-370.
3. Canadian College of Medical Geneticists and the Society of Obstetricians and Gynaecologists of Canada (CCMG/SOGC). 1993. Canadian guidelines for prenatal diagnosis of genetic disorders: An update. J SOGC 15(suppl):15-39.
4. Caron L, Dallaire L. 1996. Fréquence des anomalies chromosomiques foetales chez les femmes d'âge maternel avancé. Le médecin du Québec 31:43-49.
5. Carter CO, Evans KA. 1961. Risk of parents who have had one child with Down's syndrome (mongolism) having another child similarly affected. Lancet 2:785-788.
6. Dallaire L. 1976. Intégration du diagnostic prénatal des maladies génétiques à la pratique médicale. Can Med Assoc J 115:713-714.
7. Dallaire L, Michaud J, Mélançon SB, Potier M, Lambert M, Mitchell G, Boivert J. 1991. Prenatal diagnosis of fetal anomalies during the second trimester of pregnancy: Their characterization and delineation of defects in pregnancies at risk. Prenat Diagn 11:629-635.
8. Dallaire L, Pinsky L, Kinch L, Winsberg F. 1971. Le diagnostic prénatal en génétique médicale. Union Med Can 100:2213-2222.
9. Daniel A, Boué A, Gallano P. 1986. Prospective risk in reciprocal translocation heterozygotes at amniocentesis as determined by potential chromosome imbalance sizes. Data of the European collaborative prenatal diagnosis centers. Prenat Diagn 6:315-350.
10. Daniel A, Hook EB, Wulf G. 1989. Risks of unbalanced progeny at amniocentesis to carriers of chromosome rearrangements: Data from United States and Canadian laboratories. Am J Med Genet 31:14-53.
11. Daniel A, Stewart L, Saville T, Brookwell R, Paull H, Purvis-Smith S, Lam-Po-Tang PR. 1982. Prenatal diagnosis in 3,000 women for chromosome, X-linked, and metabolic disorders. Am J Med Genet 11:61-75.
12. Ferguson-Smith, MA, Yates JRW. 1984. Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative European study on 52,965 amniocenteses. Prenat Diagn 4: 5-44.
13. Hamerton JL, Boué A, Cohen MM, De La Chapelle A, Hsu LY, Lindsten J, Mikkelsen M, Robinson A, Stengel-Rutkowski D, Webb T, Willey A, Worton R. 1980. Chromosome disease. In: Hamerton JL, Simpson NE, editors. Prenatal diagnosis. Past, present, and future. Report of an International Workshop. Prenat Diagn (special issue). Great Yarmouth: John Wiley and Sons, p 11-21.
14. Hook EB, Cross PK, Schreinemachers DM. 1983. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 249:2034-2038.
15. Hook EB, Hamerton JL. 1977. The frequency of chromosome abnormalities detected in consecutive newborn studies, difference between studies, results by sex and by severity of phenotypic involvement. In: Hook EB, Porter H, editors. Population cytogenetics, studies in humans. New York: Academic Press, p 63-79.
16. Hunter AGW, Thompson D, Speevak M. 1987. Midtrimester genetic amniocentesis in Eastern Ontario: A review from 1970 to 1985. J Med Genet 24:335-343.
17. Lamb NE, Freeman SB, Savage-Austin A, Pettay D, Taft L, Hersey J, Gu Y, Shen J, Saker D, May KM, Avramopoulos D, Petersen MB, Hallberg A, Mikkelsen M, Hassold TJ, Sherman SL. 1996. Susceptible chiasmate configurations of chromosome 21 predispose to non-disjunction in both maternal meiosis I and meiosis II. Nat Genet 14:400-405.
18. Medical Research Council (MRC). 1977. Prenatal diagnosis of genetic disease by amniocentesis during the second trimester of pregnancy. A Canadian study. Report no. 5. Ottawa: Minister of Supply and Services, p 40.
19. Milunsky A, Atkins L. 1977. The frequency of chromosomal abnormalities diagnosed prenatally. In: Hook EB, Porter H, editors. Population cytogenetics, studies in humans. New York: Academic Press, p 11-25.
20. Sherman SL, Takaesu N, Freeman SB, Grantham M, Phillips C, Blackston RD, Jacobs PA, Cockwell AE, Freeman V, Uchida I, Mikkelsen M, Kurnit DM, Buraczynska M, Keats BJB, Hassold TJ. 1991. Trisomy 21: Association between reduced recombination and nondisjunction. Am J Hum Genet 49:608-620.
21. Stene J, Stene E, Mikkelsen M. 1984. Risk for chromosome abnormality at amniocentesis following a child with a non-inherited chromosome aberration. A European collaborative study on prenatal diagnoses. Prenat Diagn 4:81-95.
22. Van Dyke DL, Weiss L, Roberson JR, Ramesh Babu V. 1983. The frequency and mutation rate of balanced autosomal rearrangements in man estimated from prenatal genetic studies for advanced maternal age. Am J Hum Genet 35:301-308.
23. Warren AC, Chakravarti A, Wong C, Slaugenhaupt SA, Halloran SL, Watkins PC, Metaxotou C, Antonarakis SE. 1987. Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science 237:652-654.